Acrivon Therapeutics

Filed a patent for "phenyl-pyrazole carboxamide compounds" on Fri, December 23, 2022

Filed a patent for "pyrimidine carboxamide compounds" on Fri, December 30, 2022

Filed a patent for "pyrazolo-pyrimidinone compounds" on Fri, June 9, 2023

Filed a patent for "pyrazolo-pyrimidinone compounds" on Fri, December 8, 2023

Filed a patent for "methods and systems for treating disease using an atr/chk1 signaling pathway inhibitor" on Wed, July 13, 2022